Tafasitamab for the treatment of patients with diffuse large B-cell lymphoma

Volume 20, Issue 1, December 2024 .

Source: Human Vaccines and Immunotherapeutics - February 1, 2024 Category: Allergy & Immunology Authors: Maria Cristina PirosaAnastasios StathisEmanuele Zuccaa Clinic of Medical Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerlandb Institute of Oncology Research, Bellinzona, Switzerlandc Faculty of Biomedical Science, Universita ’ Source Type: research